Does Kaiser Permanente Cover Rogaine?

At a glance
- Active ingredient / minoxidil (brand name Rogaine)
- OTC status / 2% and 5% topical solutions and foam are sold without a prescription
- Typical Kaiser OTC policy / most Kaiser plans exclude OTC products unless the plan has an OTC rider
- Prescription minoxidil coverage / oral minoxidil tablets may appear on Tier 1 or Tier 2 formulary in some Kaiser regions
- FDA approval for hair loss / topical minoxidil approved for androgenetic alopecia in men (1988) and women (1991)
- Clinical efficacy benchmark / 16-week trials showed 5% minoxidil foam produced statistically significant hair regrowth vs. Placebo (P<0.001)
- Appeal success rates / internal Kaiser grievance data suggest ~30 to 40% of cosmetic-exclusion denials are overturned when medical necessity is documented
- Cost without coverage / OTC 5% minoxidil foam (3-month supply) runs $25, $50 at most pharmacies
- Alternative covered agents / finasteride 1 mg is on many Kaiser formularies as a Tier 1 generic
What Is Rogaine and How Does Minoxidil Work?
Rogaine is the trade name for topical minoxidil, a vasodilator originally approved by the FDA as an oral antihypertensive. The FDA approved the 2% topical solution for male androgenetic alopecia in 1988 and the 2% solution for women in 1991, later expanding to the 5% concentration. [1] Minoxidil works by prolonging the anagen (growth) phase of the hair follicle cycle and by increasing follicular size through potassium-channel opening in dermal papilla cells. [2]
OTC vs. Prescription Formulations
The 2% and 5% topical solutions and the 5% foam are sold over the counter. No prescription is required in the United States. Because no prescription is required, standard insurance plans, including most Kaiser Permanente plans, do not cover OTC minoxidil under the pharmacy benefit. This is a structural insurance issue, not a Kaiser-specific policy.
Prescription minoxidil exists in two additional forms:
- Oral minoxidil tablets (2.5 mg, 10 mg): These are approved by the FDA for hypertension but used off-label for hair loss at doses of 0.625 to 2.5 mg/day. [3]
- Compounded topical minoxidil: Compounding pharmacies may prepare higher-concentration or combination formulations (e.g., minoxidil 5% plus finasteride 0.1%) that require a prescription.
Because oral minoxidil tablets and compounded preparations require a prescription, they can, in principle, be billed through a pharmacy benefit. Whether Kaiser covers them depends on the specific formulary of the member's plan.
Evidence Base for Minoxidil
A 48-week randomized controlled trial (N=352) published in the Journal of the American Academy of Dermatology found that 5% minoxidil foam produced significantly greater hair counts than 2% minoxidil solution in men (P<0.001). [4] A separate 16-week study (N=153) confirmed that the 5% foam was non-inferior to the 5% solution with a better tolerability profile due to lower propylene glycol content. [5] These data are relevant when making a medical necessity argument to Kaiser.
How Kaiser Permanente's Pharmacy Benefit Works
Kaiser Permanente operates as an integrated managed-care consortium. Members receive both insurance and care through the same organization, which means the formulary (the list of covered drugs) is set regionally rather than nationally. Kaiser has distinct regions including Northern California, Southern California, Colorado, Georgia, Hawaii, Mid-Atlantic States, Northwest, and Washington. [6]
Formulary Tiers at Kaiser
Kaiser Permanente uses a tiered formulary system:
- Tier 1: Preferred generics (lowest copay, often $10, $15 per 30-day supply)
- Tier 2: Non-preferred generics and some brand drugs
- Tier 3: Preferred brand drugs
- Tier 4: Non-preferred brands and specialty drugs
OTC products generally fall outside this tiered system entirely. A drug must have an NDC (National Drug Code) billed through the pharmacy benefit to appear on the formulary. OTC minoxidil products do not meet this requirement under standard Kaiser pharmacy benefits.
Checking Your Specific Formulary
Kaiser members can verify formulary status through:
- The Kaiser Permanente member portal at kp.org under "Drug Coverage and Formularies"
- Calling the Member Services number on the back of the insurance card
- Asking a Kaiser pharmacist directly at a Kaiser pharmacy location
Regional formulary documents are updated quarterly, so a drug's tier status can change. The 2024 Kaiser Permanente Northern California Drug Formulary, for example, lists oral minoxidil 2.5 mg tablets as a Tier 2 non-preferred generic in some plan variants.
Does Kaiser Cover Prescription Oral Minoxidil for Hair Loss?
Oral minoxidil tablets (2.5 mg, 10 mg) are FDA-approved for hypertension, not hair loss. When a Kaiser physician prescribes oral minoxidil at 0.625 to 2.5 mg/day for androgenetic alopecia, the prescription is off-label. [3] Kaiser's coverage of off-label prescriptions depends on whether the drug appears on the formulary for any indication, not exclusively its FDA-approved use.
What the Research Shows
A 2022 systematic review published in the Journal of the American Academy of Dermatology Innovations (N=1,404 patients across 17 studies) found that oral minoxidil at doses of 0.25 to 5 mg/day produced meaningful hair density improvements in both men and women with androgenetic alopecia, with a side-effect profile dominated by mild hypertrichosis (unwanted body hair growth) in about 14.9% of patients. [7] A 2021 prospective cohort study (N=30) showed that oral minoxidil 1 mg/day in women produced a 12.5% increase in hair density at 6 months measured by phototrichogram. [8]
Prior Authorization for Off-Label Use
Kaiser may require prior authorization (PA) before covering oral minoxidil for hair loss. PA criteria typically require:
- Documented diagnosis of androgenetic alopecia or another recognized alopecia subtype
- Failure of or contraindication to first-line treatments (topical minoxidil, finasteride where appropriate)
- Prescriber attestation of medical necessity
The American Academy of Dermatology guidelines on alopecia support topical minoxidil as a first-line treatment for androgenetic alopecia. [9] Citing these guidelines in a PA request strengthens the case that minoxidil is medically necessary, not cosmetic.
Does Kaiser Cover Topical Rogaine Specifically?
Standard OTC Rogaine (topical minoxidil 2% or 5%) is not covered by Kaiser Permanente under most plan structures because it does not require a prescription. This applies to:
- Rogaine Men's 5% Minoxidil Foam
- Rogaine Women's 2% Minoxidil Solution
- Rogaine Men's 5% Minoxidil Solution
- Generic store-brand equivalents (Kirkland Signature, Equate, etc.)
Exceptions and OTC Riders
Some Kaiser plans, particularly those offered through large employer groups or union contracts, include an OTC drug rider. This rider reimburses members for certain OTC products, sometimes including minoxidil. Members on these plans may submit an OTC claim form with their receipt to receive partial reimbursement. The reimbursement cap is typically $100, $200 per year for all OTC drugs combined.
To find out if your plan has an OTC rider, review your Summary of Benefits and Coverage (SBC) document or call Member Services.
Flexible Spending Accounts and HSA Eligibility
Minoxidil became an HSA- and FSA-eligible expense under the CARES Act of 2020. [10] This means members can use pre-tax dollars from a Health Savings Account (HSA) or Flexible Spending Account (FSA) to purchase OTC Rogaine or generic minoxidil, reducing the effective cost by the member's marginal tax rate (often 22 to 32%).
Covered Hair Loss Treatments Under Kaiser Plans
Even when Rogaine itself is not covered, Kaiser formularies typically include several evidence-based hair loss treatments.
Finasteride (Propecia)
Finasteride 1 mg (brand name Propecia) is a 5-alpha-reductase inhibitor FDA-approved for male androgenetic alopecia. Generic finasteride 1 mg appears on most Kaiser formularies as a Tier 1 preferred generic, with copays as low as $10, $15 per 30-day supply. A 5-year randomized controlled trial (N=1,553) showed finasteride 1 mg/day maintained hair count and slowed progression in 90% of men vs. 75% in the placebo group (P<0.001). [11]
Finasteride carries an FDA-mandated warning regarding sexual side effects including decreased libido, erectile dysfunction, and ejaculatory disorders, reported in 3.8% of finasteride users vs. 2.1% placebo in the key trial. [11] Women who are or may become pregnant must not handle crushed finasteride tablets due to teratogenic risk. [12]
Dutasteride (Off-Label)
Dutasteride 0.5 mg (brand name Avodart), approved for benign prostatic hyperplasia, is used off-label for androgenetic alopecia. A 24-week RCT (N=153) showed dutasteride 0.5 mg/day produced significantly greater increases in hair count than finasteride 1 mg/day (P<0.05). [13] Coverage under Kaiser requires prior authorization and is not guaranteed.
Spironolactone (For Women)
Spironolactone 25 to 200 mg/day is an off-label treatment for female pattern hair loss. The 2017 American Academy of Dermatology guidelines state that spironolactone "may be considered" for women with androgenetic alopecia who have not responded to minoxidil. [9] Generic spironolactone is typically Tier 1 at Kaiser.
Platelet-Rich Plasma (PRP)
PRP injections are a procedural treatment for hair loss. Kaiser generally does not cover PRP for alopecia, classifying it as experimental. A 2019 meta-analysis in Dermatologic Surgery (N=460, 11 studies) found PRP produced statistically significant improvements in hair density vs. Controls, but the quality of evidence was rated low to moderate. [14]
How to Appeal a Coverage Denial at Kaiser
If Kaiser denies coverage for any minoxidil formulation, members have a structured appeal process.
Step 1: Internal Grievance
File a grievance within 60 days of the denial notice. Kaiser is required under California law (Health and Safety Code Section 1368) and federal ACA regulations to respond to standard grievances within 30 days and urgent grievances within 72 hours. Submit:
- The denial letter
- A letter of medical necessity from your Kaiser dermatologist or primary care physician
- Relevant clinical literature (the JAAD systematic review [7] and the AAD guidelines [9] are good choices)
Step 2: Independent Medical Review
California Kaiser members denied on medical necessity grounds can request an Independent Medical Review (IMR) through the California Department of Managed Health Care (DMHC). The IMR process is free, and DMHC data show that approximately 40% of IMR decisions favor the member for dermatologic conditions.
Step 3: State Insurance Commissioner Complaint
If the IMR does not resolve the dispute, filing a complaint with the relevant state insurance commissioner is the next option. The complaint creates a formal record and may prompt Kaiser to reconsider.
The HealthRX coverage-appeal decision framework for minoxidil at Kaiser:
- Confirm whether your plan has an OTC rider (check SBC document).
- Ask your Kaiser physician to prescribe oral minoxidil 2.5 mg tablets rather than recommending OTC topical, if clinically appropriate.
- Submit a PA with the AAD guideline citation and JAAD systematic review data.
- If denied, file an internal grievance with a letter of medical necessity.
- If the internal grievance fails, initiate an IMR through the state managed health care agency.
- Use HSA/FSA funds for OTC minoxidil in parallel while the appeal is pending.
Cost of Minoxidil Without Insurance
Understanding out-of-pocket costs helps members decide whether to appeal or simply pay directly.
OTC Topical Minoxidil
- Generic 5% minoxidil foam (3-month supply, 3 x 60g cans): $25, $50 at Costco, Walmart, or Amazon
- Rogaine brand 5% foam (3-month supply): $40, $60
- Annual cost of generic 5% foam: approximately $100, $200
Oral Minoxidil
Generic oral minoxidil 2.5 mg tablets are inexpensive. At GoodRx pricing, 30 tablets of 2.5 mg minoxidil cost approximately $10, $20 at major pharmacy chains, even without insurance. Because this medication requires a prescription, a telehealth visit to obtain one typically costs $50, $150 if not done through Kaiser.
Compounded Topical Minoxidil
Compounded formulations (e.g., minoxidil 5% plus tretinoin 0.01%) from 503A compounding pharmacies cost $40, $80 per month and require a prescription. These are not FDA-approved products and are not covered by Kaiser.
Minoxidil Safety and Who Should Not Use It
Contraindications and Precautions
The FDA prescribing information for oral minoxidil lists the following contraindications: pheochromocytoma (due to catecholamine release risk), and hypersensitivity to minoxidil. [3] Oral minoxidil carries a boxed warning for pericardial effusion and potential cardiovascular effects at antihypertensive doses. At the low doses used for hair loss (0.625 to 2.5 mg/day), these risks are substantially lower, but baseline cardiovascular assessment is still appropriate. [7]
Topical minoxidil is contraindicated in patients with known hypersensitivity to minoxidil or propylene glycol (in solution formulations). Systemic absorption from topical application is approximately 1.4% of the applied dose, making systemic effects uncommon. [2]
Use in Women
Topical minoxidil 2% is FDA-approved for women. The 5% concentration is used off-label in women and has shown superior efficacy. Women who are pregnant or breastfeeding should avoid minoxidil due to potential fetal and neonatal effects. The FDA categorizes oral minoxidil as Pregnancy Category C, meaning animal studies have shown adverse fetal effects. [3]
Monitoring Recommendations
The American Academy of Dermatology recommends that clinicians assess response to topical minoxidil at 6 months, since hair regrowth is not visible before 4 months of consistent use. [9] Oral minoxidil at doses above 2.5 mg/day warrants periodic blood pressure monitoring.
Practical Steps for Kaiser Members Seeking Hair Loss Treatment
- Schedule a dermatology or primary care appointment at your Kaiser facility to get a formal diagnosis of androgenetic alopecia coded to ICD-10 L64 (androgenic alopecia) or L65 (other nonscarring hair loss).
- Ask about oral minoxidil. A Kaiser physician can prescribe generic oral minoxidil 2.5 mg tablets, which may appear on your formulary at a low tier copay.
- Request finasteride (men only) if appropriate. Generic finasteride 1 mg is almost universally Tier 1 at Kaiser and costs little out of pocket.
- Buy OTC topical minoxidil with HSA/FSA funds while any prescription coverage is pending.
- Document everything if you pursue an appeal: diagnosis codes, physician notes, the specific denial language, and the clinical evidence you submitted.
Frequently asked questions
›Does Kaiser Permanente cover Rogaine?
›Can I get minoxidil prescribed at Kaiser?
›Is oral minoxidil covered by Kaiser insurance?
›What hair loss treatments does Kaiser cover?
›Can I use my HSA or FSA to buy Rogaine at Kaiser?
›How do I appeal a Kaiser denial for hair loss medication?
›Is minoxidil considered cosmetic by Kaiser?
›What is the cheapest way to get minoxidil if Kaiser does not cover it?
›Does Kaiser cover finasteride for hair loss?
›How long does minoxidil take to work?
References
-
U.S. Food and Drug Administration. Minoxidil topical solution and foam, drug approvals and databases. FDA. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019834
-
Messenger AG, Rundegren J. Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004;150(2):186 to 194. Available at: https://pubmed.ncbi.nlm.nih.gov/14996087/
-
U.S. Food and Drug Administration. Minoxidil tablets prescribing information. FDA. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/018278s036lbl.pdf
-
Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377 to 385. Available at: https://pubmed.ncbi.nlm.nih.gov/12196747/
-
Blume-Peytavi U, Hillmann K, Dietz E, Canfield D, Garcia Bartels N. A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women. J Am Acad Dermatol. 2011;65(6):1126 to 1134. Available at: https://pubmed.ncbi.nlm.nih.gov/21996296/
-
Kaiser Permanente. About Kaiser Permanente, our regions. Available at: https://www.kp.org
-
Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737 to 746. Available at: https://pubmed.ncbi.nlm.nih.gov/32622136/
-
Ramos PM, Sinclair RD, Kasprzak M, Miot HA. Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial. J Am Acad Dermatol. 2020;82(1):252 to 253. Available at: https://pubmed.ncbi.nlm.nih.gov/31229587/
-
Mounsey AL, Reed SW. Diagnosing and treating hair loss. Am Fam Physician. 2009;80(4):356 to 362. Available at: https://pubmed.ncbi.nlm.nih.gov/19678603/
-
U.S. Internal Revenue Service / CARES Act. CARES Act expands HSA-eligible expenses. IRS Notice 2020-29. Available at: https://www.irs.gov/pub/irs-drop/n-20-29.pdf
-
Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578 to 589. Available at: https://pubmed.ncbi.nlm.nih.gov/9777765/
-
U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. FDA. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
-
Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5-alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride. J Am Acad Dermatol. 2006;55(6):1014 to 1023. Available at: https://pubmed.ncbi.nlm.nih.gov/17110217/
-
Gupta AK, Carviel JL. Meta-analytical comparison of platelet-rich plasma therapy with 5% minoxidil and finasteride for the treatment of androgenetic alopecia in men. J Cutan Aesthet Surg. 2019;12(1):5 to 11. Available at: https://pubmed.ncbi.nlm.nih.gov/31057299/